136 related articles for article (PubMed ID: 24783515)
1. [Co-delivery of paclitaxel and cyclosporine by a novel liposome-silica hybrid nano-carrier for anti-tumor therapy via oral route].
Deng L; Su TT; Huang XL; Wang YH; Li C
Yao Xue Xue Bao; 2014 Jan; 49(1):106-14. PubMed ID: 24783515
[TBL] [Abstract][Full Text] [Related]
2. The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles.
Bao QY; Zhang N; Geng DD; Xue JW; Merritt M; Zhang C; Ding Y
Int J Pharm; 2014 Dec; 477(1-2):408-15. PubMed ID: 25455782
[TBL] [Abstract][Full Text] [Related]
3. Rational design of hybrid nanomicelles integrating mucosal penetration and P-glycoprotein inhibition for efficient oral delivery of paclitaxel.
Lian H; He Z; Meng Z
Colloids Surf B Biointerfaces; 2017 Jul; 155():429-439. PubMed ID: 28463810
[TBL] [Abstract][Full Text] [Related]
4. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of cyclosporin enables oral therapy with paclitaxel.
Meerum Terwogt JM; Beijnen JH; ten Bokkel Huinink WW; Rosing H; Schellens JH
Lancet; 1998 Jul; 352(9124):285. PubMed ID: 9690410
[No Abstract] [Full Text] [Related]
6. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
Jain S; Kumar D; Swarnakar NK; Thanki K
Biomaterials; 2012 Oct; 33(28):6758-68. PubMed ID: 22748771
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity.
Patel K; Patil A; Mehta M; Gota V; Vavia P
Int J Pharm; 2014 Sep; 472(1-2):214-23. PubMed ID: 24954663
[TBL] [Abstract][Full Text] [Related]
8. Application of rotatable central composite design in the preparation and optimization of poly(lactic-co-glycolic acid) nanoparticles for controlled delivery of paclitaxel.
Kollipara S; Bende G; Movva S; Saha R
Drug Dev Ind Pharm; 2010 Nov; 36(11):1377-87. PubMed ID: 20545520
[TBL] [Abstract][Full Text] [Related]
9. Drug Carrier-Oriented Polygeline for Preparing Novel Polygeline-Bound Paclitaxel Nanoparticles.
Xiong K; Wu J; Liu Y; Wu N; Ruan J
J Pharm Sci; 2019 Jun; 108(6):2012-2021. PubMed ID: 30639741
[TBL] [Abstract][Full Text] [Related]
10. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies.
Zhao L; Feng SS
J Pharm Sci; 2010 Aug; 99(8):3552-60. PubMed ID: 20564384
[TBL] [Abstract][Full Text] [Related]
11. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K
Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344
[TBL] [Abstract][Full Text] [Related]
12. The construction and characterization of hybrid paclitaxel-in-micelle-in-liposome systems for enhanced oral drug delivery.
Li Y; Chen Z; Cui Y; Zhai G; Li L
Colloids Surf B Biointerfaces; 2017 Dec; 160():572-580. PubMed ID: 29028605
[TBL] [Abstract][Full Text] [Related]
13. Bile salt liposomes for enhanced lymphatic transport and oral bioavailability of paclitaxel.
Zhang B; Xue A; Zhang C; Yu J; Chen W; Sun D
Pharmazie; 2016 Jun; 71(6):320-6. PubMed ID: 27455550
[TBL] [Abstract][Full Text] [Related]
14. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
Zabaleta V; Ponchel G; Salman H; Agüeros M; Vauthier C; Irache JM
Eur J Pharm Biopharm; 2012 Aug; 81(3):514-23. PubMed ID: 22516136
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral bioavailability of docetaxel by coadministration of cyclosporine: quantitation and role of P-glycoprotein.
Chiou WL; Wu TC; Ma C; Jeong HY
J Clin Oncol; 2002 Apr; 20(7):1951-2; author reply 1952. PubMed ID: 11919259
[No Abstract] [Full Text] [Related]
17. Ionically fixed polymeric nanoparticles as a novel drug carrier.
Lee SW; Chang DH; Shim MS; Kim BO; Kim SO; Seo MH
Pharm Res; 2007 Aug; 24(8):1508-16. PubMed ID: 17380262
[TBL] [Abstract][Full Text] [Related]
18. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.
Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM
Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480
[TBL] [Abstract][Full Text] [Related]
19. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and drug release property of paclitaxel nanoparticles].
Wang TW; Wu Y; Li MJ; Gao HX
Zhong Yao Cai; 2009 Sep; 32(9):1447-9. PubMed ID: 20034226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
